Chapter 1. Lung Immune Defences in the Immunosuppressed Patient

  1. Carlos Agustí3,4 and
  2. Antoni Torres3,4
  1. Naimish Patel1,2 and
  2. Henry Koziel1,2

Published Online: 7 JUL 2009

DOI: 10.1002/9780470714171.ch1

Pulmonary Infection in the Immunocompromised Patient: Strategies for Management

Pulmonary Infection in the Immunocompromised Patient: Strategies for Management

How to Cite

Patel, N. and Koziel, H. (2009) Lung Immune Defences in the Immunosuppressed Patient, in Pulmonary Infection in the Immunocompromised Patient: Strategies for Management (eds C. Agustí and A. Torres), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470714171.ch1

Editor Information

  1. 3

    Cap de Servei de Pneumologia i Allèrgia Respiratòria Hospital Clínic de Barcelona, Barcelona, Spain

  2. 4

    Institut Clinic de Pneumologia ICPCT, Hospital Clinic, C/Villarroel, 170, 08036 Barcelona, Spain

Author Information

  1. 1

    Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA

  2. 2

    Division of Pulmonary, Critical Care and Sleep Medicine, Kirstein Hall, Room E/KSB-23, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA

Publication History

  1. Published Online: 7 JUL 2009
  2. Published Print: 27 JAN 2009

ISBN Information

Print ISBN: 9780470319574

Online ISBN: 9780470714171

SEARCH

Keywords:

  • lung immune defences in immunosuppressed patient;
  • secreted antimicrobial factors in airways;
  • innate immunity in lungs;
  • lungs and adaptive immunity;
  • host defence function in select immunocompromised patients;
  • neutrophil function abnormalities in HIV infected individuals;
  • immunodeficiency and collagen vascular disease;
  • barrier and pharmacological defences and innate immune and adaptive immune systems

Summary

This chapter contains sections titled:

  • Introduction

  • Host defence function in health

  • Host defence function in select immunocompromised patients

  • Summary and future directions for this field

  • References